Panos Konstantinopoulos, MD, PhD shares results of a phase 2 endometrial cancer study at 2022 SGO.
2 مناظر
administrator
07/17/23
Panos Konstantinopoulos, MD, PhD shares results of a phase 2, two-stage study of letrozole and abemaciclib in estrogen receptor (ER) positive recurrent or persistent endometrial cancer at the 2022 Society for Gynecologic Oncology Annual Meeting.
مزید دکھائیں
فیس بک کے تبصرے
کوئی تبصرہ نہیں ملا